Johnson & Johnson (NYSE: JNJ) has completed its previously announced public offerings of $5 billion in aggregate principal amount of senior notes. The offerings include $750 million of 4.500% notes due 2027, $750 million of 4.550% notes due 2028, $1 billion of 4.700% notes due 2030, $1.25 billion of 4.850% notes due 2032, and $1.25 billion of 5.000% notes due 2035. The company entered into an underwriting agreement on February 18, 2025, with Citigroup Global Markets Inc., BofA Securities, Inc., and J.P. Morgan Securities LLC as representatives of the underwriters.